Amgen’s Tavneos Main Approval Study Retracted by New England Journal of Medicine

A clinical trial used to approve Amgen Inc.’s pill Tavneos was retracted Monday from the New England Journal of Medicine, putting the drug’s continued sales at risk, according to Bloomberg.